{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:26:17Z","timestamp":1790439977296,"version":"4.1.0"},"reference-count":19,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI144112, R01-AI078881, R01GM121600"],"award-info":[{"award-number":["R01AI144112, R01-AI078881, R01GM121600"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Mathematical modeling of Ebola virus (EBOV)\u2013host dynamics during infection and treatment in vivo is in its infancy due to few studies with frequent viral kinetic data, lack of approved antiviral therapies, and limited insight into the timing of EBOV infection of cells and tissues throughout the body. Current in-host mathematical models simplify EBOV infection by assuming a single homogeneous compartment of infection. In particular, a recent modeling study assumed the liver as the largest solid organ targeted by EBOV infection and predicted that nearly all cells become refractory to infection within seven days of initial infection without antiviral treatment. We compared our observations of EBOV kinetics in multiple anatomic compartments and hepatocellular injury in a critically ill patient with Ebola virus disease (EVD) with this model\u2019s predictions. We also explored the model\u2019s predictions, with and without antiviral therapy, by recapitulating the model using published inputs and assumptions. Our findings highlight the challenges of modeling EBOV\u2013host dynamics and therapeutic efficacy and emphasize the need for iterative interdisciplinary efforts to refine mathematical models that might advance understanding of EVD pathogenesis and treatment.<\/jats:p>","DOI":"10.3390\/v12010106","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T04:14:41Z","timestamp":1579234481000},"page":"106","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Modeling Challenges of Ebola Virus\u2013Host Dynamics during Infection and Treatment"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-1728","authenticated-orcid":false,"given":"Daniel S.","family":"Chertow","sequence":"first","affiliation":[{"name":"Critical Care Medicine Department, National Institutes of Health Clinical Center, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Shekhtman","sequence":"additional","affiliation":[{"name":"The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Medical Center, Maywood, IL 60153, USA"},{"name":"Network Science Institute, Northeastern University, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Lurie","sequence":"additional","affiliation":[{"name":"Liver Unit, Shaare Zedek Medical Center and the Hebrew University of Jerusalem, Jerusalem 9103102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Davey","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[{"name":"Translational Hepatology Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-1817","authenticated-orcid":false,"given":"Harel","family":"Dahari","sequence":"additional","affiliation":[{"name":"The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Medical Center, Maywood, IL 60153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Erb-Alvarez, J., Wendelboe, A.M., and Chertow, D.S. (2019). Ebola Virus in the Democratic Republic of the Congo: Advances and Remaining Obstacles in Epidemic Control, Clinical Care, and Biomedical Research. Chest.","DOI":"10.1016\/j.chest.2019.08.2183"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.1038\/s41598-017-08884-0","article-title":"Windows of opportunity for Ebola virus infection treatment and vaccination","volume":"7","author":"Nguyen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2016.10.004","article-title":"Modelling Ebola virus dynamics: Implications for therapy","volume":"135","author":"Martyushev","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1038\/s41467-018-06215-z","article-title":"Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies","volume":"9","author":"Madelain","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7326\/M15-3066","article-title":"Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report","volume":"165","author":"Chertow","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/cid\/cix518","article-title":"Evidence of Ebola Virus Replication and High Concentration in Semen of a Patient During Recovery","volume":"65","author":"Barnes","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kash, J.C., Walters, K.A., Kindrachuk, J., Baxter, D., Scherler, K., Janosko, K.B., Adams, R.D., Herbert, A.S., James, R.M., and Stonier, S.W. (2017). Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aai9321"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2036.2010.04549.x","article-title":"The natural history of acute hepatitis C: Clinical presentation, laboratory findings and treatment outcomes","volume":"33","author":"Loomba","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Shteyer, E., Shekhtman, L., Zinger, T., Harari, S., Gafanovich, I., Wolf, D., Ivgi, H., Barsuk, R., Dery, I., and Armoni, D. (2019). Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212252"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/path.4456","article-title":"Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses","volume":"235","author":"Martines","year":"2015","journal-title":"J. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The Pathogenesis of Ebola Virus Disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1093\/infdis\/jiw254","article-title":"Ebola Virus Shedding and Transmission: Review of Current Evidence","volume":"214","author":"Vetter","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.20548","article-title":"Serum alanine aminotransferase in skeletal muscle diseases","volume":"41","author":"Nathwani","year":"2005","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S1473-3099(15)00144-9","article-title":"Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: An observational cohort study","volume":"15","author":"Hunt","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/civ779","article-title":"Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in Guinea","volume":"62","author":"Cournac","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","first-page":"171","article-title":"Nonhuman Primate Models of Ebola Virus Disease","volume":"411","author":"Bennett","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"PREVAIL II Writing Group, Multi-National PREVAIL II Study Team, Davey, R.T., Dodd, L., Proschan, M.A., Neaton, J., Neuhaus Nordwall, J., Koopmeiners, J.S., Beigel, J., and Tierney, J. (2016). A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N. Engl. J. Med., 375, 1448\u20131456.","DOI":"10.1056\/NEJMoa1604330"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mulangu, S., Dodd, L.E., Davey, R.T., Tshiani Mbaya, O., Proschan, M., Mukadi, D., Lusakibanza Manzo, M., Nzolo, D., Tshomba Oloma, A., and Ibanda, A. (2019). A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa1910993"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/1\/106\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:26:32Z","timestamp":1760365592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/1\/106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["v12010106"],"URL":"https:\/\/doi.org\/10.3390\/v12010106","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,16]]}}}